Author

Michael Trailor

Observed name: Michael A. Trailor

Institutions: Harvard University, Massachusetts General Hospital

Observed institutions: Harvard University, Massachusetts General Hospital

OpenAlex ID: A5073166403

Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)

2022 · Marc Wehrli, Kathleen Gallagher, et al. · Journal for ImmunoTherapy of Cancer · 140

Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma

2025 · Matthew J. Frigault, Ning Yao, et al. · Blood Advances · 19

A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

2021 · Matthew J. Frigault, Kathleen M.E. Gallagher, et al. · Blood · 14

Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood

2024 · Won‐Ho Lee, Charlotte E. Graham, et al. · Cytometry Part B Clinical Cytometry · 9

Tisagenlecleucel Demonstrates Safety, Efficacy and CNS Trafficking in Primary CNS Lymphoma

2021 · Matthew J. Frigault, Jorg Dietrich, et al. · Blood · 5

CAR-T Cell Therapy in Recurrent Primary CNS Lymphoma (PCNSL): A Phase 2 Clinical Trial (S27.009)

2022 · Jorg Dietrich, Yi-Bin Chen, et al. · Neurology · 2

Works count: 6

Citation count: 189

H-index: 5

I10-index: 3